Cargando…
Iron-Induced Hepatocarcinogenesis—Preventive Effects of Nutrients
The liver is a primary organ that stores body iron, and plays a central role in the regulation of iron homeostasis. Hepatic iron overload (HIO) is a prevalent feature among patients with chronic liver diseases (CLDs), including alcoholic/nonalcoholic liver diseases and hepatitis C. HIO is suggested...
Autor principal: | Tsuchiya, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271801/ https://www.ncbi.nlm.nih.gov/pubmed/35832553 http://dx.doi.org/10.3389/fonc.2022.940552 |
Ejemplares similares
-
Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
por: Yamamoto, Naoki, et al.
Publicado: (2016) -
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
por: Fabregat, Isabel, et al.
Publicado: (2018) -
CSTF2 Promotes Hepatocarcinogenesis and Hepatocellular Carcinoma Progression via Aerobic Glycolysis
por: Chen, Zhimin, et al.
Publicado: (2022) -
Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis
por: Wang, Ting, et al.
Publicado: (2021) -
3,5,3′-Triiodothyronine–Loaded Liposomes Inhibit Hepatocarcinogenesis Via Inflammation-Associated Macrophages
por: Sun, Gangqi, et al.
Publicado: (2022)